This blog features posts from multiple departments of the National Brain Tumor Society. From keeping you updated on the research advancements, to providing insight into our public policy advocacy efforts, we want to keep you informed of how NBTS as an organization is here for you. Questions or comments? Email questions@braintumor.org.
“We’re in it all the way”
“We are all in this together,” said Daniel Gallahan, PhD, Deputy Director of the Division of Cancer Biology, National Cancer Institute, at this afternoon’s systems biology panel discussion. “If we understand fundamental changes [that lead to progress] in one disease, we can extrapolate to other diseases.” Afterward, there was a robust discussion among government, industry, and others in the brain tumor community about the challenges and complexity of moving systems biology research forward quickly so that the research can be translated into better therapies.
N. Paul TonThat, Executive Director of the National Brain Tumor Society, passionately described both the frustration and the challenges involved in calling on the scientific community to refocus their efforts and accelerate development of new treatments for brain tumors.
To close the afternoon, Michael Berens, PhD, Professor and Director of the Cancer and Cell Biology Division of TGen, eloquently reminded the community that we are all trying to do something that no one else has done. Although there will be unavoidable challenges along the way, this effort promises to have a huge impact.
It was a great day filled with tons of information! And we're only on day 2! Looking forward to the Patient and Family Reception and the Patient and Family Program tomorrow.
